All companies, by market cap
508 companies and 2253 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Revenue | Quarter |
|---|---|---|---|---|---|
| 376 |
|
$258B | $697.00 −1.7% | $47.4B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 TMO Thermo Fisher Scientific |
| 377 |
|
$258B | $62.08 +0.0% | $49.7B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 NFLX Netflix |
| 378 |
|
$260B | $894.55 −3.6% | $66.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 GS Goldman Sachs |
| 379 |
|
$269B | $199.80 +0.2% | $96.0B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 RTX RTX |
| 380 |
|
$270B | $424.30 −10.8% | $151.2B Last four quarters 2027: Q1, Q2 · 2026: Q3, Q4 | Q2 FY27 DELL Dell Technologies |
| 381 |
|
$275B | $300.84 −3.4% | $20.8B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 TXN Texas Instruments |
| 382 |
|
$286B | $622.75 −3.8% | $74.7B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 CAT Caterpillar |
| 383 |
|
$299B | $239.11 −6.0% | $26.1B Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 LRCX Lam Research |
| 384 |
|
$299B | $365.87 −3.9% | $3.4B 1 of four quarters in a row 2026: Q4 | Q4 FY26 PANW Palo Alto Networks |
| 385 |
|
$310B | $390.09 −7.5% | $30.8B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 AMAT Applied Materials |
| 386 |
|
$313B | $301.80 −3.6% | $52.6B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 GE GE Aerospace |
| 387 |
|
$325B | $208.79 +0.1% | $43.1B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 PM Philip Morris International |
| 388 |
|
$328B | $329.20 +0.1% | $169.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 HD Home Depot |
| 389 |
|
$332B | $65.76 −28.6% | $59.9B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 INTC Intel |
| 390 |
|
$365B | $406.97 −1.0% | $450.1B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 UNH UnitedHealth |
| 391 |
|
$369B | $149.52 +2.2% | $48.6B 3 of four quarters in a row 2025: Q1, Q2, Q3 | Q3 FY25 MRK Merck & Co. |
| 392 |
|
$376B | $161.57 +0.6% | $87.9B Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 PG Procter & Gamble |
| 393 |
|
$395B | $130.67 −6.4% | $71.8B Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 ORCL Oracle |
| 394 |
|
$405B | $94.08 +1.4% | $13.4B 1 of four quarters in a row 2026: Q3 | Q3 FY26 KO Coca-Cola |
| 395 |
|
$412B | $104.51 −3.8% | $63.3B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 CSCO Cisco |
| 396 |
|
$442B | $184.11 −6.3% | $6.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 PLTR Palantir Technologies |
| 397 |
|
$449B | $1,012.28 +1.8% | $303.2B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 COST Costco |
| 398 |
|
$521B | $294.89 +1.4% | $64.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ABBV AbbVie |
| 399 |
|
$559B | $638.01 +0.4% | $36.3B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 MA Mastercard |
| 400 |
|
$658B | $273.20 −0.7% | $74.8B 3 of four quarters in a row 2026: Q1, Q2, Q3 | Q3 FY26 JNJ Johnson & Johnson |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.